Deciphera Pharmaceuticals
The Scientist III will independently design, execute, and optimize biochemical and cell‑based high‑throughput assays, leveraging automation platforms to generate decision‑making data for small‑molecule drug discovery. The role involves collaborating with cross‑functional teams, managing CRO studies, and contributing to assay development and data analysis to accelerate the design‑make‑test‑analyze cycle.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
22% below the average for this role
Research Associate - Biology Automation
Recursion
Senior Assay and Automation Scientist
AstraZeneca
Scientist II, Assay Operations, Screening Platform Technologies (SPT)
Revolution Medicines
Scientist II/Senior Scientist I, InVitro Pharmacology
Zealand Pharma
Scientist II/Senior Scientist I, InVitro Pharmacology
Zealand Pharma
Open Rank Scientist – Cell Biology
Novo Nordisk A/S